Inactive Instrument
Company Constellation Pharmaceuticals, Inc.
Stocks
CNST
US2103731061
Biotechnology & Medical Research
Business description: Constellation Pharmaceuticals, Inc.
Number of employees: 154
Sales by Activity: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Geographical breakdown of sales: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Executive Committee: Constellation Pharmaceuticals, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
John McKenna
PSD | President | - | - |
Kia Khalaghpour
IRC | Investor Relations Contact | - | - |
Irina Apostolou
PRN | Corporate Officer/Principal | - | 2016-07-31 |
Brenda J. Sousa
COO | Chief Operating Officer | 62 | 2017-03-31 |
Composition of the Board of Directors: Constellation Pharmaceuticals, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2021-07-14 | |
John McKenna
BRD | Director/Board Member | - | - |
Company details: Constellation Pharmaceuticals, Inc.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.43% | +2.49% | +61.83% | +115.25% | 52.88B | |
| +1.58% | +19.37% | +75.37% | +85.18% | 50.98B | |
| -0.23% | -0.98% | -14.12% | -16.00% | 22.81B | |
| +0.98% | +9.05% | -0.36% | +423.40% | 22.43B | |
| +2.03% | +7.40% | +28.79% | -12.32% | 17.01B | |
| +0.88% | +5.78% | +30.82% | -34.26% | 15.91B | |
| +0.68% | +2.54% | +22.28% | +168.03% | 13.29B | |
| +3.02% | +12.74% | +143.33% | +308.04% | 13.58B | |
| +0.79% | +1.59% | +85.06% | +116.18% | 11.75B | |
| Average | +1.57% | +5.90% | +48.11% | +128.17% | 24.52B | |
| Weighted average by Cap. | +1.99% | +6.54% | +49.87% | +120.53% |
